LifeX Ventures

LifeX predicts… https://lnkd.in/e8zdWtEq

We're excited to share some updates at Concentro! 🚀 Over the summer, we raised a $3M seed round led by firstminute capital with participation from LifeX Ventures, Silence, Plug and Play Tech Center, Avesta Fund, Calafia Iberia, a doubling down from our pre-seed investors J Ventures, Dorm Room Fund, & Contour Venture Partners, as well as participation from a host of amazing strategic angels. We couldn’t be more happy with the investor group we’ve assembled. The round will help us accelerate towards our goal of making tax credit transfers seamless and accessible for clean energy developer sellers as well as corporate and individual buyers. Moreover, it will give us the resources to build the right technology tools to streamline transactions and diligence, as well as to launch financing products beyond tax credit transfers, in line with our mission to create a one-stop-shop for clean energy projects to get financed. Since the fundraise, we have been keeping very busy: - We have over $300m in tax credits ready to be financed on the platform across more than 60 developers. - We closed multiple transactions, including transacting with a Fortune 50 all the way down to closing one of the smallest transactions ($99k!) in the industry. - We assembled a stellar team that we are incredibly excited about. - We have made exciting inroads in developing AI tools to enhance underwriting processes and unlocking smaller scale transactions (under $10M). We recently spoke with Jennifer P. Roig at NPM US (New Project Media) who wrote a piece on all things Concentro, you can find a link in the comments👇. We’re grateful to our team, investors, & partners who have been part of our journey so far, and are excited for what’s to come! CC: Brett Schneider, Enrique Apellaniz, Anna Lulushi, Marcos Pardo García, Tom Stilwell, Liz Studlick Sam Endacott, Will Wells, Adriana Vitagliano, John Nordin, Inaki Berenguer, Borja Moreno de los Rios, Guilherme Penna, Srikant Vasan, George Damouny, Molly Fowler, Owen Davis, Gioia Cerbelli, Jason Liao, Anthony Valente, Felipe Morenés Botín, Hugo Arévalo Álvarez-Arenas, Miguel Fernandez Larrea, Przemek Gotfryd, Ignacio Bachiller Ströhlein, Felipe Navío, Ángel Agudo, Duncan Grierson. #cleanenergy #taxcredits #projectfinance #seedround

LifeX Ventures Fellows Chris Bradbury and Aditri Bhagirath hosted the Stanford Founders Demo Day. Their event showcased 9 exceptional startups, drew an audience of 200+ Stanford students, and brought together over 50 leading venture capitalists. Here’s a snapshot of the 9 startups that took the stage: 🎨 Renderpub: AI-powered architectural rendering redefining design 📚 AI-Learners: Revolutionizing EdTech with personalized AI-driven learning 🏥 Aether AI: Next-gen clinical decision support system empowering healthcare providers 🚗 HyperThread AI: Enhancing supplier visibility in automotive and aerospace 💸 Exo AI: Transforming FinTech with intelligent AI agents 🤖 Otom.ai: Autonomous complex sales agents leveraging federated data 🌸 Devaki Life Sciences: Breakthrough consumer health technologies for women ⏱️ Vita Innovations: Safer, faster, and smarter emergency room care ☕ CoffeeSpace: Smart cofounder matching for ambitious entrepreneurs We’re thrilled to have Chris and Aditri leading the #Healthcare and #AI verticals for Stanford Founders, and we can’t wait to see what continues to come from the future monthly events. cc Amol Sarva Inaki Berenguer Rika Christanto Veeral Mehta Fabian Siegel

Great to see Dave Johnson, Ely Porter and Ander Tallett introduce Dash Bio to the world in the WSJ. Dash Bio is transforming the analysis of clinical trial samples using #robotics, #AI, and #software. By eliminating manual processes, they are helping accelerate drug development, reducing time and cost. The team’s expertise comes from their time leading software engineering and AI initiatives at Moderna, where they built and led a 150-person team as former Chief Data and AI Officer. Thrilled to support you on this journey, alongside Freestyle Capital and Swift Ventures. "Moderna Alums Launch Biotech-Services Startup Dash Bio" https://lnkd.in/dykWvyZw #labautomation #bio #AI #robotics cc Amol Sarva Inaki Berenguer Fabian Siegel Rika Christanto Veeral Mehta

Announcing the 2024-25 cohort of LifeX Ventures Fellows from Harvard Business School, Stanford University Graduate School of Business, and MIT Sloan School of Management! We launched the LifeX Fellowship in 2023 to connect with the next generation of founders at the schools we know so well. As alumni ourselves, we recognize these institutions as breeding grounds for transformative ideas. LifeX Fellows are our thought partners on campus. We provide them access to our playbooks for investing and building companies, so they can support their campus peers and beyond. Each fellow brings unique expertise, having worked at leading tech companies like Apple, Slack, LinkedIn, Lyft, and Uber, and shares a deep passion for areas such as AI, life sciences, platforms, and networks. Welcome to the LifeX team: - Grace Lee (Harvard University) grace@lifex.vc - Alona King (Massachusetts Institute of Technology) alona@lifex.vc - Chris Bradbury (Stanford University) chris@lifex.vc Learn more about their backgrounds here: https://www.lifex.vc/team Founders and VCs, please reach out! cc Inaki Berenguer Veeral Mehta Amol Sarva Amalia Formoso Lisa Kleinsorge Rika Christanto

We are excited to announce our investment in Limula, as they democratize access to Cell and Gene Therapies. We are thrilled to do it alongside Verve Ventures Oxford Seed Fund Zühlke Group Lichtsteiner Foundation and a group of angels. Limula's team is driven by the ambitious goal of developing tools based on a fundamentally novel way of manipulating cells outside of the body. Their technology supports manufacturing workflows that are currently impossible to automate with existing tools. Automation powered by hardware, AI, and software is the only route to scalability and digital traceability. Since the first CAR-T cell therapy was approved in 2017, over 20,000 cancer patients have been treated. However, this is not enough; current costs are prohibitive (over $500K to treat a single patient), and capacity is limited. The tools have lagged behind scientific and clinical advancements, and these therapies' production is still very manual. Globally, less than 3% of patients who could benefit from these therapies have been able to access them. Limula is the solution to democratize access to new CAR-T, TCR-T, NK, and other life-saving cell and gene therapies. If you are a clinical center, biotech, or CDMO, Limula is expanding its partnerships and would be happy to chat. Reach out to partnerships@limula.ch to start a conversation. https://lnkd.in/dkeFjpBm cc Amol Sarva Rika Christanto Inaki Berenguer Yue Zhao Amalia Formoso Luc Henry Thomas Eaton Yann Pierson Caroline Boudousquié Olivier Waridel